ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The company is aiming to transform the treatment of mental health disorders.
CNBC
MarketWatch
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.